A Difficult Case of Optic Neuropathy: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Celine Noha Haeller; Thierry Badoux; Friedrich Medlin; Lionel Arlettaz; Philippe DeGottrau; Eva Grams; Manolito Lucas Finger; Vincent Dunet; Marie-Claire Gaillard

doi:10.1055/a-2218-8352

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2024; 241(04): 551-553
DOI: 10.1055/a-2218-8352

Der interessante Fall

A Difficult Case of Optic Neuropathy: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Ein schwieriger Fall optischer Neuropathie: Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierte Erkrankung (MOGAD)

Celine Noha Haeller

¹Ophthalmology, HFR, Fribourg, Switzerland

,

Thierry Badoux

²Neurology, HFR, Fribourg, Switzerland

,

Friedrich Medlin

²Neurology, HFR, Fribourg, Switzerland

,

Lionel Arlettaz

³Allergology and Clinical Immunology, Hôpital du Valais, Sion, Switzerland

,

Philippe DeGottrau

¹Ophthalmology, HFR, Fribourg, Switzerland

,

Eva Grams

¹Ophthalmology, HFR, Fribourg, Switzerland

,

Manolito Lucas Finger

¹Ophthalmology, HFR, Fribourg, Switzerland

,

Vincent Dunet

⁴Medical Radiology, CHUV, Lausanne, Switzerland

,

Marie-Claire Gaillard

¹Ophthalmology, HFR, Fribourg, Switzerland

› Author Affiliations

Abstract

Full Text

References

References
1 Messias K, Marques VD, Messias A. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis: an update. Arq Bras Oftalmol 2022; 86: 83-92
2 Banwell B, Bennett JL, Marignier R. et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 2023; 22: 268-282
3 Sechi E, Cacciaguerra L, Chen JJ. et al. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management. Front Neurol 2022; 13: 885218
4 Chen JJ, Flanagan EP, Jitprapaikulsan J. et al. Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol 2018; 195: 8-15
5 Foo R, Yau C, Singhal S. et al. Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore. Asia Pac J Ophthalmol (Phila) 2022; 11: 184-195
6 Cobo-Calvo A, Sepúlveda M, Rollot F. et al. Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease. J Neuroinflammation 2019; 16: 134
7 Jarius S, Ruprecht K, Kleiter I. et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 2016; 13: 280
8 Lopez JA, Houston SD, Tea F. et al. Validation of a Flow Cytometry Live Cell-Based Assay to Detect Myelin Oligodendrocyte Glycoprotein Antibodies for Clinical Diagnostics. J Appl Lab Med 2022; 7: 12-25
9 Waters PJ, Komorowski L, Woodhall M. et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology 2019; 92: e1250-e1255